Is Applied Therapeutics Inc halal to invest in?

As of July 2026, Applied Therapeutics Inc APLT is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Applied Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Applied Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Applied Therapeutics Inc?

Muslim investors may consider investing in Applied Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Applied Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Applied Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Applied Therapeutics Inc updated?

The Shariah compliance status of Applied Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Applied Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Applied Therapeutics Inc?

You can check the latest Shariah compliance status of Applied Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

APLT Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Applied Therapeutics Inc is classified as not halal.

NOT HALAL

Report Source: 2025 3rd Quarter Report

Applied Therapeutics Inc. Stock Analysis APLT

United States Health Care Nano Cap Report: Q3, 2025

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. The company is headquartered in New York City, New York and currently employs 28 full-time employees. The company went IPO on 2019-05-09. The Company’s lead drug candidate, govorestat, is a central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including classic galactosemia, sorbitol dehydrogenase (SORD) deficiency and phosphomannomutase 2 (PMM2)-congenital disorder glycosylation (CDG). The firm is also developing AT-001, an investigational, ARI developed as an oral therapy for the treatment of diabetic cardiomyopathy (DbCM). The company has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type II diabetes. The Company’s pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, and has demonstrated strong retinal penetrance, for the treatment of diabetic retinopathy (DR).

Key Statistics of Applied Therapeutics Inc (APLT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.10$0.11

Today's Open

$0.10

Volume

2.70M

P/E Ratio (TTM)

52 Week Range

$0.09$1.50

Market Cap

14.83M

Avg. Volume

10.78M

Dividend Yield

Financial Metrics & Statements of Applied Therapeutics Inc (APLT)

Super Investors Invested in Applied Therapeutics Inc (APLT)

FAQ's for Applied Therapeutics Inc (APLT)

As of July 2026, Applied Therapeutics Inc APLT is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Applied Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Applied Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Applied Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Applied Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Applied Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.